Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 04, 2024 09:00 ET | Source: Parexel International LLC

Parexel Named “Best Contract Research Organization” at 17th Annual Vaccine Industry Excellence (ViE) Awards

DURHAM, N.C., April 04, 2024 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...
March 18, 2024 09:05 ET | Source: Parexel International LLC

Parexel Announces CEO Succession Plan

DURHAM, N.C., March 18, 2024 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...
February 01, 2024 09:00 ET | Source: Parexel International LLC

Parexel Appoints Susan R. Salka to Board of Directors

DURHAM, N.C., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...
January 10, 2024 08:55 ET | Source: Parexel International LLC

Parexel and Japanese Foundation for Cancer Research Announce Strategic Alliance

DURHAM, N.C. and TOKYO, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development...
November 17, 2023 07:30 ET | Source: Parexel International LLC

Parexel Named “Best Contract Research Organization” at 19th Annual Scrip Awards

DURHAM, N.C., Nov. 17, 2023 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...
November 08, 2023 08:55 ET | Source: Parexel International LLC

Parexel Named 2023 Healthcare Businesswomen’s Association ACE Award Honoree

DURHAM, N.C., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...
October 12, 2023 08:55 ET | Source: Parexel International LLC

Global Investigative Sites Recognize Parexel with the 2023 Society for Clinical Research Sites Eagle Award

DURHAM, N.C., Oct. 12, 2023 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...
September 20, 2023 08:55 ET | Source: Parexel International LLC

Parexel’s Amy McKee, M.D. Named to 2023 PharmaVoice 100

DURHAM, N.C., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...
September 19, 2023 08:55 ET | Source: Parexel International LLC

Parexel Appoints Gwyn Bebb, BM, BCh., Ph.D., to Lead Oncology Clinical Development

DURHAM, N.C., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...
August 15, 2023 07:00 ET | Source: Parexel International LLC

Parexel and Partex Announce Innovative Alliance Leveraging Artificial Intelligence and Big Data to Accelerate Drug Discovery and Development

Collaboration combines clinical research expertise with artificial intelligence capabilities to help drug developers better understand the probability of clinical success for their assets ...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right